Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
UK prescribing follows NICE guidance (TA875, TA664), with access typically restricted to specialist weight management services for patients meeting specific BMI and comorbidity criteria
Increased Accessibility: With more manufacturers producing the drug, its likely to be available to a wider segment of the population
Studies show that patients taking semaglutide have high satiety levels, contributing to less consumption of fatty foods
Dose reduction of these agents may be necessary
Cash-pay does at least bring the benefit of clearer, upfront numbers
And so we are also hoping to partner with the Legislature and the administration on addressing some of those payer practices
US$ 27.22
US$ 27.14
US$ 27.95
US$ 24.91
